Topics

Trifecta bioprosthesis midterm results.

08:00 EDT 9th July 2019 | BioPortfolio

Summary of "Trifecta bioprosthesis midterm results."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: The Annals of thoracic surgery
ISSN: 1552-6259
Pages:

Links

DeepDyve research library

PubMed Articles [7500 Associated PubMed Articles listed on BioPortfolio]

Trifecta Aortic Bioprosthesis: Midterm Results in 1,953 Patients from a Single Center (Commentary).

Transaortic Transcatheter Aortic Valve Implantation: Learning Curve, Perioperative, and Midterm Follow-Up Results of a Single Center.

We present our initial institutional experience with transaortic (TAo) transcatheter aortic valve implantation (TAVI) using a self-expanding aortic bioprosthesis.

Endoscopic Robot-Assisted Simple Enucleation of Renal Tumours: Impact of Learning Curve and Tumour Complexity on Trifecta Outcomes.

In this article, we report the outcomes of endoscopic robot-assisted tumour enucleation (ERASE) using a trifecta system.

The Stented Porcine Bioprosthesis: A 50-year journey through hopes and realities.

The year 2018 has marked the 50 anniversary of the first implant of a commercially manufactured stented porcine bioprosthesis. During the subsequent years considerable clinical and pathological resear...

Transprosthetic cuff leakage of a bovine pericardial aortic bioprosthesis.

The Carpentier-Edwards PERIMOUNT Magna aortic heart valve is the most frequently implanted bioprosthesis. However, the existence of transvalvular cuff leakage necessitating a second cross clamp has be...

Clinical Trials [1167 Associated Clinical Trials listed on BioPortfolio]

Aortic Valve Replacement With Trifecta(TM)

The purpose of this study is to confirm the clinical safety and effectiveness of the Trifecta valve.

Aortic Valve Replacement With Trifecta(TM)

To confirm the clinical safety and effectiveness of the Trifecta valve.

Trifecta™ GT Post Market Clinical Follow-up

The objective of this study is to evaluate the safety and performance of the Trifecta™ GT (Glide Technology) valve through 5 year follow-up in a prospective, multi-center, real-world set...

ATS 3f Enable(tm) Aortic Bioprosthesis, Model 6000

This is a prospective, non-randomized, multi-center study designed to evaluate safety and effectiveness of the ATS 3f Enable Aortic Bioprosthesis in a patient population undergoing isolate...

Comparison of TrIfecta and Perimount Magna Ease

The hemodynamic performance of two supraannular aortic xenografts (Trifecta, St. Jude Medical and Perimount Magna Ease, Edwards Lifescience) will be compared using rest- and stress echocar...

Medical and Biotech [MESH] Definitions

A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material.

The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.

Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers.

Assessments aimed at determining agreement in diagnostic test results among laboratories. Identical survey samples are distributed to participating laboratories, with results stratified according to testing methodologies.

Test results which deviate substantially from normal ranges of REFERENCE VALUES or other qualitative results. They trigger CLINICAL LABORATORY SERVICES to place a special alert to ensure PATIENT SAFETY.

Quick Search


DeepDyve research library

Searches Linking to this Article